NFH
MDGL icon

NEXT Financial Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

NEXT Financial Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3K Buy
+25
New +$3.11K ﹤0.01% 1387

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NEXT Financial Holdings's MDGL Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2019: 25 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1387 among its holdings.

135 funds tracked by Wall St. Rank hold MDGL as of Q1 2019.

  • NEXT Financial Holdings held 25 shares of Madrigal Pharmaceuticals worth $3K as of Q1 2019.
  • Madrigal Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
  • Madrigal Pharmaceuticals made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1387 holding.
  • 135 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.